Related references
Note: Only part of the references are listed.The Innovative Medicines Initiative: an engine for regulatory science
Michel Goldman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Multicompany trials adapt to disciplines beyond cancer
Asher Mullard
NATURE MEDICINE (2014)
Lung cancer trial aims to bolster personalized medicine
Charlotte Harrison
NATURE REVIEWS DRUG DISCOVERY (2014)
Large personalised medicine trial in lung cancer heralds new research partnership
Ingrid Torjesen
BMJ-BRITISH MEDICAL JOURNAL (2014)
Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials
Scott M. Berry et al.
CLINICAL TRIALS (2013)
Reports from the 2010 Clinical and Translational Cancer Research Think Tank Meeting: Design Strategies for Personalized Therapy Trials
Donald A. Berry et al.
CLINICAL CANCER RESEARCH (2012)
Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
Apostolia-Maria Tsimberidou et al.
CLINICAL CANCER RESEARCH (2012)
Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL-CALGB 150007/150012, ACRIN 6657
Laura J. Esserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adaptive clinical trials in oncology
Donald A. Berry
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
The BATTLE Trial: A Bold Step toward Improving the Efficiency of Biomarker-Based Drug Development
Eric H. Rubin et al.
CANCER DISCOVERY (2011)
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim et al.
CANCER DISCOVERY (2011)
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
A. D. Barker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
Kristine R. Broglio et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Bayesian clinical trials
DA Berry
NATURE REVIEWS DRUG DISCOVERY (2006)
Share Paper
